Stock Events

Stock Events

Travere Therapeutics (TVTX) Q3 2023 Earnings

7NovConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-1.17

-0.02

1.12

2.27

Details

Expected EPS

N/A

Actual EPS

2.27

Surprise EPS

2.27

Surprise Percent

+∞%

Description

Travere Therapeutics (TVTX) has reported earnings of 2.27 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.